Medical device and MedTech insights, news, tips and more

Artificial Pancreas Trials To Begin In The U.S. 

January 11, 2016

Artifical Pancreas

Artifical Pancreas

Illustration of male pancreas anatomy

In the U.S. alone, 1.25 million Americans suffer from type 1 diabetes, a potentially debilitating and life-changing condition. Every year, more and more people are diagnosed, and the only common treatment is regular insulin injections. A research team hoping to revolutionize diabetes treatment has developed an artificial pancreas that automatically detects changing blood sugar levels and administers insulin automatically, as announced by Harvard University.

The pancreas is responsible for producing a range of hormones within our body, including insulin, which helps to control the levels of sugar (glucose) in our blood. Those who do not manage to control their blood sugar level – by either not producing enough insulin (type 1) or by producing ineffective insulin (type 2) – tend to develop hyperglycemia.

Frequently injecting insulin is the normal method of treatment, but there are increasingly more advanced methods being trialled and tested in medical laboratories and institutions across the world. Just this week, a team of researchers in California have developedinsulin-producing beta cells by manipulating the development of human skin cells; these can be transplanted straight into mice, where they are shown to be effective at preventing the onset of diabetes.

Read More & See Video: Source: Artificial Pancreas Trials To Begin In The U.S. | IFLScience

January 9, 2016 | by Robin Andrews

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.